WCN26-6849 PREDICTING IGA NEPHROPATHY PROGRESSION: A HISTOPATHOLOGICAL APPROACH USING PARIETAL EPITHELIAL CELLS AND PODOCYTE MARKERS - PARCC IgAN Score

Read full text Summarise with VIRAT
Authors: Jean‐Daniel Delbet, Marie‐Cécile Perier, Mathilde Baudin, Olivia Boyer, Tim Ulinski, Corinne Lesaffre, Léa Resmini, Jean Philippe Empana, Alexandre Karras, David Buob, Chloé Broudin, Geoffrey Teixeira
+3 more Olivia Lenoir, Marion Rabant, Pierre‐Louis Tharaux
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

IgA nephropathy (IgAN) presents with a highly variable clinical course. The heterogeneity of IgAN trajectories and the lack of detailed phenotyping remain obstacles for better outcome prediction and potentially endotype delineation. Although an international risk prediction tool has been developed based on demographic, clinical, and histological features, it does not incorporate molecular or pathophysiological data. Early glomerular alterations, such as parietal epithelial cell (PEC) activation or podocyte injury, may offer additional prognostic insights.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104373–104373
Publication date
25 March 2026
Language
EN